Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Japanese Prescription Drug Market Could Grow To ¥9 Trillion In 2016

This article was originally published in PharmAsia News

Executive Summary

Japanese marketing research company Tokyo-based Yano Research Institute estimates the therapeutic drug market in Japan will reach ¥9.16 trillion by 2016, a 23-percent increase compared to total sales in 2008. The reasons cited are a strong demand for drugs by an increasingly aging population coupled with healthcare reform centered on drug re-pricing policies that is estimated to slow down over the years. According to Yano Research, the single biggest factor impacting the market is the national price reduction policy conducted every two years. The company also estimated the market could shrink to ¥7.24 trillion if the re-pricing policy is to further accelerate. (Click here for more - Japanese language



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts